Dillon & Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,659
Closed -$263K 70
2019
Q3
$263K Sell
2,659
-10,534
-80% -$1.04M 0.08% 61
2019
Q2
$1.21M Sell
13,193
-47,693
-78% -$4.39M 0.38% 42
2019
Q1
$5.72M Sell
60,886
-3,450
-5% -$324K 1.86% 23
2018
Q4
$4.12M Sell
64,336
-8,220
-11% -$526K 1.57% 27
2018
Q3
$6.46M Buy
72,556
+1,065
+1% +$94.8K 2.14% 22
2018
Q2
$5.65M Buy
71,491
+9,835
+16% +$777K 2.09% 21
2018
Q1
$5.49M Buy
61,656
+9,612
+18% +$855K 2.12% 20
2017
Q4
$5.41M Buy
52,044
+4,321
+9% +$449K 2.04% 20
2017
Q3
$6.97M Buy
47,723
+850
+2% +$124K 2.75% 13
2017
Q2
$6.09M Buy
46,873
+2,095
+5% +$272K 2.51% 16
2017
Q1
$5.55M Buy
44,778
+1,188
+3% +$147K 2.36% 16
2016
Q4
$5.06M Buy
43,590
+595
+1% +$69K 2.3% 18
2016
Q3
$4.51M Buy
42,995
+1,040
+2% +$109K 2.08% 20
2016
Q2
$4.15M Buy
41,955
+1,195
+3% +$118K 1.91% 23
2016
Q1
$4.08M Buy
40,760
+2,240
+6% +$224K 1.89% 22
2015
Q4
$4.62M Buy
38,520
+780
+2% +$93.6K 2.23% 19
2015
Q3
$4.08M Buy
37,740
+1,350
+4% +$146K 2.04% 22
2015
Q2
$4.22M Buy
36,390
+1,387
+4% +$161K 2.06% 22
2015
Q1
$4.03M Buy
35,003
+1,408
+4% +$162K 1.93% 22
2014
Q4
$3.76M Buy
33,595
+1,875
+6% +$210K 1.83% 23
2014
Q3
$3.01M Buy
31,720
+965
+3% +$91.7K 1.54% 26
2014
Q2
$2.64M Buy
30,755
+4,675
+18% +$402K 1.36% 27
2014
Q1
$1.83M Buy
26,080
+2,610
+11% +$183K 0.98% 30
2013
Q4
$1.98M Buy
23,470
+370
+2% +$31.3K 1.07% 29
2013
Q3
$1.79M Buy
23,100
+470
+2% +$36.4K 1% 32
2013
Q2
$1.32M Buy
+22,630
New +$1.32M 0.85% 38